The scent of love is in the air(way): a potential drug target for sleep apnea?-Reference-Cited by-同舟云学术

The scent of love is in the air(way): a potential drug target for sleep apnea?

Published:2023-01-31 Issue:4 Volume:46 Page:
ISSN:0161-8105
Container-title:SLEEP
language:en
Short-container-title:

Author:

Osman Amal M¹,Altree Thomas J¹²,Eckert Danny J¹^ORCID

Affiliation:

1. Adelaide Institute for Sleep Health/Flinders Health and Medical Research Institute Sleep Health, College of Medicine and Public Health, Flinders University , Adelaide , Australia

2. Respiratory Medicine Unit, The Queen Elizabeth Hospital, Central Adelaide Local Health Network , Woodville , Australia

Funder

National Health and Medical Research Council

Publisher

Oxford University Press (OUP)

Subject

Physiology (medical),Neurology (clinical)

Link

https://academic.oup.com/sleep/advance-article-pdf/doi/10.1093/sleep/zsad019/49293673/zsad019.pdf

Reference44 articles.

1. Defining phenotypic causes of obstructive sleep apnea. Identification of novel therapeutic targets;Eckert;Am J Respir Crit Care Med.,2013

2. The combination of atomoxetine and oxybutynin greatly reduces obstructive sleep apnea severity. A randomized, placebo-controlled, double-blind crossover trial;Taranto-Montemurro;Am J Respir Crit Care Med.,2019

3. A resource of potential drug targets and strategic decision-making for obstructive sleep apnoea pharmacotherapy;Horner;Respirology.,2017

4. Phenotypic approach to pharmacotherapy in the management of obstructive sleep apnoea;Aishah;Curr Opin Pulm Med.,2019

5. The noradrenergic agent reboxetine plus the antimuscarinic hyoscine butylbromide reduces sleep apnoea severity: a double-blind, placebo-controlled, randomised crossover trial;Lim;J Physiol.,2021

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacological management of co-morbid obstructive sleep apnoea and insomnia;Expert Opinion on Pharmacotherapy;2023-12-12

2. Targets for obstructive sleep apnea pharmacotherapy: principles, approaches, and emerging strategies;Expert Opinion on Therapeutic Targets;2023-07-03